A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2011
11/24/2011	US20110286928 Methods and compositions for inhibition of BCL6 repression
11/24/2011	US20110286927 ATF4 Inhibitors and Their Use for Neural Protection, Repair, Regeneration, and Plasticity
11/24/2011	US20110286926 Degradable hydrogel compositions and methods
11/24/2011	US20110286925 Embolizing Sclerosing Hydrogel
11/24/2011	US20110286924 Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
11/24/2011	US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
11/24/2011	US20110286922 Imaging and radiotherapy methods
11/24/2011	US20110286917 Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer
11/24/2011	US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
11/24/2011	US20110286915 Nanocarriers for Drug Delivery
11/23/2011	EP2388264A1 Compound retained in tumor
11/23/2011	EP2180902B1 Imaging medium comprising hyperpolarised ¹³c-acetate and use thereof
11/23/2011	EP1954321B1 Method of dynamic nuclear polarisation (dnp) using a trityl radical and a paramagnetic metal ion
11/23/2011	EP1749026B1 Labelled adrenomedullin derivatives and their use for imaging and therapy
11/23/2011	EP1644941B1 Method of manufacturing magnetic nanoparticles having improved magnetic properties
11/23/2011	CN1897978B Assembly of gas-filled microvesicle with active component for contrast imaging
11/23/2011	CN102256628A Smart contrast agents for mri imaging
11/23/2011	CN102256627A Dye solution
11/23/2011	CN102256596A Liposomal composition for convection-enhanced delivery to the central nervous centre
11/23/2011	CN102250840A Human pancreatic cancer cell line and its application
11/23/2011	CN102250277A Macromolecular polymer capable of carrying medicine and used for embolism
11/23/2011	CN102247607A Method for preparing bacteriostatic couplant
11/23/2011	CN101884795B Fluorescent nano probe of nuclease activated type and preparation method thereof
11/23/2011	CN101791414B Multifunctional EPR bio-probe based on magnetic nano particle and application thereof
11/22/2011	US8062643 Use of neurotoxin therapy for treatment of urologic and related disorders
11/22/2011	US8062625 Cancer immunotherapy predictive parameters
11/22/2011	CA2662278C Methods and compositions for increasing patient tolerability during myocardial imaging methods
11/22/2011	CA2482973C Microparticles comprising carbohydrate beads covalently linked with allergen
11/22/2011	CA2258518C Recognition molecules interacting specifically with the active site or cleft of a target molecule
11/17/2011	WO2011143562A2 Il-1 binding proteins
11/17/2011	WO2011143524A2 Functional, cross-linked nanostructures for tandem optical imaging and therapy
11/17/2011	WO2011143360A2 Compositions, methods and systems for the synthesis and use of imaging agents
11/17/2011	WO2011143128A2 Multi-phasic nanostructures for imaging and therapy
11/17/2011	WO2011141766A1 Ferritin biosensor and methods of using the same
11/17/2011	WO2011141705A1 Novel cationic lipids and methods of use thereof
11/17/2011	WO2011113616A9 A nanoparticle comprising a micelle formed by an amphiphilic block- copolymer and encapsulating a gadolinium complex
11/17/2011	WO2011071968A3 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
11/17/2011	US20110283370 Mouse model for depression, schizophrenia and alzheimer's disease and the use thereof
11/17/2011	US20110280947 Embolization
11/17/2011	US20110280811 Method of measuring propulsion in lymphatic structures
11/17/2011	US20110280810 Surgical optical systems for detecting brain tumors
11/17/2011	US20110280809 Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
11/17/2011	US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
11/17/2011	US20110280807 Methods and Models for Stress-Induced Analgesia
11/17/2011	US20110280806 Dye conjugate imaging agents
11/17/2011	US20110280805 Neurotoxic sterol glycosides
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	CA2799468A1 Functional, cross-linked nanostructures for tandem optical imaging and therapy
11/17/2011	CA2799091A1 Novel cationic lipids and methods of use thereof
11/17/2011	CA2799046A1 Il-1 binding proteins
11/16/2011	EP2386630A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386629A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2385845A1 Contrast media compositions
11/16/2011	EP1652533B1 Heart-slowing drug containing short-acting beta-blocker as the active ingredient
11/16/2011	CN102242081A Super paramagnetic iron oxide particle marked cell for magnetic-resonance tracing in vivo
11/16/2011	CN102239821A Human hemangioma animal model and constructing method and application thereof
11/16/2011	CN101123995B Stilbene derivatives and their use for binding and imaging amyloid plaques
11/16/2011	CN101107016B Contrast agents to target extracellular matrix
11/15/2011	US8057807 Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	US8057783 Method of injecting liquid agents at acupuncture points to arrive internal organs and method of visualizing arrival of liquid agents
11/15/2011	CA2422635C In vitro assay for measuring the immunogenicity of a vaccine
11/15/2011	CA2410387C Polymerizable compositions and methods of use
11/15/2011	CA2257851C Modulators of tissue regeneration
11/10/2011	WO2011140525A2 Methods and compositions related to a retinoid receptor-selective pathway
11/10/2011	WO2011140519A2 In vivo gelling pharmaceutical pre-formulation
11/10/2011	WO2011140517A2 Methods for treating diseases of the lung
11/10/2011	WO2011140193A1 Implantable dissolved oxygen sensor and methods of use
11/10/2011	WO2011138975A1 High density poly-alkylene glycol-coated iron oxide gold core-shell nanoparticle
11/10/2011	WO2011138462A1 Diagnostic method for the detection of cells ex vivo
11/10/2011	WO2011138269A1 Hyperpolarized lactate contrast agent for determination of ldh activity
11/10/2011	WO2011137514A1 Imageable activatable agent for radiation therapy and method and system for radiation therapy
11/10/2011	WO2011059263A3 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
11/10/2011	WO2010119362A8 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
11/10/2011	US20110276344 Method for diagnosing food allergy
11/10/2011	US20110274626 Pulse sequencing with hyperpolarisable nuclei
11/10/2011	US20110274625 Liposomal Composition for Convection-Enhanced Delivery to the Central Nervous Centre
11/10/2011	US20110274624 Contrast agents in porous particles
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	US20110274622 Nanocrystal Nano-Emulsion
11/10/2011	US20110274621 Active Particles for Bio-Analytical Applications and Methods for Their Preparation
11/10/2011	US20110274620 Multifunctional degradable nanoparticles with control over size and functionalities
11/10/2011	US20110274619 Brain tumor targeting peptides and methods
11/10/2011	US20110274618 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof
11/10/2011	US20110274617 Antibody-Targeted Carrier For Contrast Agents
11/09/2011	EP2384769A2 Ophthalmic visualization compositions and methods of using same
11/09/2011	EP2384323A1 Intravascular contrast agents
11/09/2011	EP2384203A1 Contrast agents for medical microwave imaging
11/09/2011	EP2193115B1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method
11/09/2011	EP1062337B1 Human n-type calcium channel isoform and uses thereof
11/09/2011	CN102239130A Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
11/09/2011	CN102238968A Animal model for evaluating vasomotor response in vivo
11/09/2011	CN102238966A Transport-mediating colloidal pharmaceutical compounds
11/09/2011	CN102238908A Method for measuring physiological parameters in cerebral interstitial fluid and cerebral extracellular space
11/09/2011	CN102234679A Preparation method of tumor detection nanoprobe
11/09/2011	CN102233139A Acetylcysteine effervescent tablet and preparation method and application thereof
11/09/2011	CN102233138A Chemical composition for target imaging
11/09/2011	CN102233134A Slit-Robo-mediated lymph vessel formation and application
11/09/2011	CN101811192B Water-soluble monodisperse iron-nickel magnetic nanoparticles and application thereof

1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 354